← Back to feedRead original →
VERIFIEDET Markets·negative
US market drag keeps Dr Reddy's, Cipla under pressure despite strong product pipeline
AI Summary
- ·Dr Reddy's and Cipla reported reduced net profits and operating margins in the June quarter due to a decline in their US business.
- ·The companies' domestic businesses demonstrated strong performance, contributing positively to their overall results.
- ·Future growth is anticipated from obesity therapies and specialty product launches, though analysts have lowered earnings forecasts.